Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin C Creelan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung CancerAlexa B Schrock, Allison Welsh, Jon H Chung, et al.
Patient Education and Counseling|December 3, 2017
Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation programGwendolyn P Quinn, Rebecca D Pentz, Teresita Muñoz-Antonia, et al.
Journal of Neurosurgery|January 22, 2023
Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy aloneAmmoren E Dohm, Joseph D Tang, Matthew N Mills, et al.
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
Cancer Medicine|November 21, 2019
A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analysesTheresa A Boyle, Gwendolyn P Quinn, Matthew B Schabath, et al.
JAMA Oncology|February 15, 2024
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical TrialPeter W Szlosarek, Benjamin C Creelan, Thomas Sarkodie, et al.
Nature Cancer|May 9, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapyChao Wang, Xiaoqing Yu, Jamie K Teer, et al.
Nature Medicine|August 13, 2021
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trialBenjamin C Creelan, Chao Wang, Jamie K Teer, et al.
Cancer Cell|April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerMatthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung CancerAlexa B Schrock, Allison Welsh, Jon H Chung, et al.
Patient Education and Counseling|December 3, 2017
Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation programGwendolyn P Quinn, Rebecca D Pentz, Teresita Muñoz-Antonia, et al.
Journal of Neurosurgery|January 22, 2023
Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy aloneAmmoren E Dohm, Joseph D Tang, Matthew N Mills, et al.
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.
Cancer Medicine|November 21, 2019
A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analysesTheresa A Boyle, Gwendolyn P Quinn, Matthew B Schabath, et al.
JAMA Oncology|February 15, 2024
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical TrialPeter W Szlosarek, Benjamin C Creelan, Thomas Sarkodie, et al.
Nature Cancer|May 9, 2025
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapyChao Wang, Xiaoqing Yu, Jamie K Teer, et al.
Nature Medicine|August 13, 2021
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trialBenjamin C Creelan, Chao Wang, Jamie K Teer, et al.
Cancer Cell|April 17, 2018
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung CancerMatthew D Hellmann, Tavi Nathanson, Hira Rizvi, et al.
Pageof 2